The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.50
Bid: 28.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.571%)
Open: 28.50
High: 28.50
Low: 28.50
Prev. Close: 28.50
PEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Major New Contract Award & Contracts Update

8 Nov 2018 10:31

RNS Number : 7798G
Pennant International Group PLC
08 November 2018
 

FOR IMMEDIATE RELEASE 08 November 2018

 

 

PENNANT INTERNATIONAL GROUP PLC

 

 

Major Contract Award valued at up to c. C$30 million

&

Contracts Update

 

 

Pennant International Group plc ("Pennant" or the "Group"), the AIM quoted supplier of integrated training and support solutions, products and services which train and assist operators and maintainers in the defence and regulated civilian sectors, is pleased to provide the following update on recent contract developments.

 

Integrated Logistics Support

 

The Canadian government has awarded a new consulting services contract to Pennant Canada Limited for the use and optimisation of Pennant's OmegaPS suite of supportability software which is used throughout the Canadian Department for National Defence ("DND"), further extending the 18-year consultancy relationship between Pennant and the DND.

 

The contract provides a framework which allows for services to be called upon on an 'as and when required basis' for an initial two-year term with the option to extend until November 2023. The initial value of the two-year framework is C$11.9 million, with the overall value (for the full five years) being in the region of C$30 million (as against C$19.7 million for the previous contract).

 

Pennant's OmegaPS and OmegaPS Analyzer are the Logistic Support Analysis and Life Cycle Costing software products of choice for the DND and have been used extensively throughout the department since the early 1990s.

 

Philip Walker, Pennant CEO commented: "We are delighted to have secured this new contract with the Canadian DND, which is testament to the close, long-standing partnership Pennant has with the DND. The award confirms the capability and value of the OmegaPS suite and provides a firm foundation for the continued expansion of the Group's consulting business globally."

 

Technical Documentation

 

Pennant has also secured an initial order from a new customer (a prime rail car builder) for the provision of technical documentation services. The value of the order is not being disclosed but is expected to grow over time and builds on the Group's extensive experience and well-established reputation in technical documentation services in the rail sector.

 

Training Solutions

 

Furthermore, the Group has made good progress in negotiations relating to the potential contract first announced on 9 August 2018 for the design, build and delivery of training equipment to an undisclosed customer for which it has been 'down-selected'. Preliminary exchanges of data are ongoing and preparatory works are under way. It is currently anticipated that the customer will formally award the contract in either late 2018 or during the first half of 2019. The potential value of the contract (£25 million to £30 million) remains unchanged.

 

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

 

Enquiries:

 

Pennant International Group plc

www.pennantplc.co.uk

Philip Walker, CEO

David Clements, Commercial & Risk Director

+44 (0) 1452 714 914

 

 

WH Ireland Limited

www.whirelandcb.com

Mike Coe

+44 (0) 117 945 3470

 

 

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann / Tom Cooper

+44 (0)20 7933 8780

+44 (0)7768 807631

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CNTUWURRWKAARAA
Date   Source Headline
24th Apr 20242:44 pmRNSNotice of Results and Appointment of Board Adviser
7th Feb 20247:00 amRNSAppointment of Non-executive Director
7th Feb 20247:00 amRNSYear-End Trading Update
22nd Nov 202311:41 amRNSHolding(s) in Company
15th Nov 20235:20 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNS2023 Interim Results
11th Sep 20237:00 amRNSNew Strategic Partnership
7th Sep 20237:00 amRNSPennant attending DSEI, London
19th Jul 20237:00 amRNSTrading Update & Notice of Interim Results
10th Jul 202310:39 amRNSIssue of Equity, Director Dealings & TVR
13th Jun 20237:00 amRNSBusiness Update: New Contract Wins
7th Jun 202310:40 amRNSResult of AGM
23rd May 202310:45 amRNSHolding in Company
22nd May 20233:15 pmRNSHolding in Company
16th May 202312:21 pmRNSHolding in Company
27th Apr 202311:31 amRNSNotice of AGM & Posting of 2022 Annual Accounts
26th Apr 20237:00 amRNS2022 Final Results
20th Apr 20237:00 amRNSNotice of 2022 Final Results
13th Apr 20237:00 amRNSAcquisition of UK Rail Services Business
16th Mar 20232:00 pmRNSHolding(s) in Company
14th Mar 20235:30 pmRNSHolding(s) in Company
23rd Feb 20231:13 pmRNSAppointment of Chair
8th Feb 202311:05 amRNSSecond Price Monitoring Extn
8th Feb 202311:00 amRNSPrice Monitoring Extension
8th Feb 20237:00 amRNSYear-end Trading Update
19th Jan 20239:31 amRNSHolding(s) in Company
12th Jan 202312:47 pmRNSAppointment of Director
9th Nov 20227:00 amRNSShare Option Restructuring
24th Oct 20228:31 amRNSDirectorate Change
21st Sep 20227:00 amRNS2022 Interim Results
9th Aug 20225:51 pmRNSIssue of Equity, Director/PDMR Dealings & TVR
9th Aug 202210:32 amRNSHoldings in Company
3rd Aug 20227:00 amRNSSale of Pennant Court
28th Jul 20227:00 amRNSTrading Update & Notice of Interim Results
30th Jun 20227:00 amRNSNotice of Capital Markets Day
22nd Jun 202210:27 amRNSResult of AGM
27th May 202210:56 amRNSNotice of AGM
25th May 20227:00 amRNS2021 Final Results
29th Apr 20227:00 amRNSNotice of Final Results
19th Apr 20221:42 pmRNSHolding in Company
6th Apr 20227:00 amRNSIssue of Equity, Director/PDMR Dealings & TVR
23rd Mar 20227:00 amRNSContracts & Order Book Update
21st Jan 202210:19 amRNSMajor Programme Update
20th Jan 20229:05 amRNSSecond Price Monitoring Extn
20th Jan 20229:00 amRNSPrice Monitoring Extension
20th Jan 20227:00 amRNSTrading Update
16th Dec 202110:55 amRNSHolding in Company
3rd Dec 202111:20 amRNSMajor Programme Update
17th Nov 202112:04 pmRNSHolding in Company
11th Nov 20215:13 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.